A new study from the ISARIC 4C and UK Coronavirus Immunology Consortium teams, published this afternoon, looks at the key biological factors that characterise and distinguish severe and fatal COVID-19.
The panel were able to discuss the global reach of ISARIC 4C and the importance of preparedness in a pandemic.
Journalists dialled in to hear the study investigators present their results and answer any questions.
Dr Ryan Thwaites, Research Associate, National Heart and Lung Institute, Imperial College London
Dr Kenneth Baillie, Academic Consultant in Critical Care Medicine, Roslin Institute, University of Edinburgh, and ISARIC 4C lead
Dr Gail Carson, Consultant in Infectious Diseases, University of Oxford and Director of Network Development at ISARIC
Prof Peter Openshaw, Professor of Experimental Medicine, Imperial College London, and ISARIC 4C co-lead